Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | E2F2 |
| Upstream (Parents) |
|---|
| (<<) E2F7 → E2F2 |
| (<<) RUNX3 → E2F2 |
| (<<) L3MBTL4 → E2F2 |
| (<<) ZEB1 → E2F2 |
| (<<) ZNF367 → E2F2 |
| (<<) UHRF1 → E2F2 |
| (<<) HMGB2 → E2F2 |
| (<<) PTTG1 → E2F2 |
| (<<) MYBL2 → E2F2 |
| Downstream (Children) |
|---|
| E2F2 → CDKN2A (>>) |
| E2F2 → IRX2 (>>) |
| E2F2 → MEOX2 (>>) |
| E2F2 → BNC1 (>>) |
| E2F2 → CTBP1 (>>) |
| E2F2 → SOX7 (>>) |
| E2F2 → ZNF165 (>>) |
| E2F2 → DMRT2 (>>) |
| E2F2 → MESP1 (>>) |
| E2F2 → ELF3 (>>) |
| E2F2 → E2F8 (>>) |
| E2F2 → LHX2 (>>) |
| E2F2 → KLF4 (>>) |
| E2F2 → TSHZ2 (>>) |
| E2F2 → LMO4 (>>) |
| E2F2 → HR (>>) |
| E2F2 → GRHL3 (>>) |
| E2F2 → TFDP1 (>>) |
| E2F2 → MYCL1 (>>) |
| E2F2 → OVOL1 (>>) |
| E2F2 → POU4F1 (>>) |
| E2F2 → ZNF281 (>>) |
| E2F2 → HEYL (>>) |
| E2F2 → TCF3 (>>) |
| E2F2 → ELF4 (>>) |
| E2F2 → KLF12 (>>) |
| E2F2 → MEIS3P1 (>>) |
| E2F2 → TCEAL1 (>>) |
| E2F2 → C11orf9 (>>) |
